Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. We have built a culture where innovative and talented people thrive—focusing a significant effort on attracting and retaining passionate and motivated employees who want to play a role in helping people with serious health conditions and who see this effort as personally rewarding. In our highly entrepreneurial environment, employees are empowered and the opportunity for professional development occurs every day.
The Director, Scientific Communications will serve as a key scientific leader within Medical Affairs responsible for the development, oversight, and execution of scientific content supporting Celldex’s immunology portfolio. This individual will partner cross-functionally with Medical Affairs & Evidence Generation, Clinical Development, Clinical Science, HEOR, Biostatistics, Regulatory, Commercial, and external scientific experts to ensure the delivery of high-quality, scientifically rigorous, and compliant medical and scientific content across multiple channels and audiences.
This role will lead scientific communication initiatives supporting Celldex’s clinical programs, including scientific platforms, congress materials, external scientific content (e.g., slide decks), internal training materials, medical information content, advisory board materials, FAQs, field medical resources, and related scientific communications. The individual will work closely with the Director, Scientific Publications to ensure alignment between broader scientific communications, publication strategy, and scientific communications. The ideal candidate will bring strong scientific acumen, medical writing expertise, and the ability to translate complex clinical and scientific data into clear, accurate, and impactful medical content as Celldex advances multiple late-stage immunology assets toward commercialization.
Software Powered by ICIMS
www.icims.com